Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of the investor meetings27-09-2021
27-09-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor Meeting with IIFL Asset Management Company24-09-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor Meeting with IIFL Asset Management Company24-09-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor meetings23-09-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of meeting to be held on September 22, 202121-09-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
IIFL''s US / UK virtual conference21-09-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attached with the Schedule of Investor Meetings16-09-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investor meeting schedule with Asset Management One and Sands Capital Management11-09-2021
Gland Pharma management on Covid vaccine opportunity
Gland Pharma's management is also focused on the manufacture of Sputik light as well, Motilal Oswal said in a note09-09-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for the CEO track forum - Motilal Oswal 17th Annual Global Investor Conference to be held on September 8, 202107-09-2021